Our presentation is part of the session on Computational Toxicology – The Cutting-edge of In Silico Prediction, and is titled "Applications of Artificial Intelligence in Preclinical Drug Efficacy and Safety Testing."
Come visit us at booth #702, and see our poster titled "Artificial Intelligence Enables Structural Toxicity Testing for Endpoint and Multiple-Timepoint Assays".
Dana Solutions announced today that it will receive a subaward from the Health and Environmental Sciences Institute (HESI) as part of a multi-year U01 grant from the FDA.
Come see our poster T-3222 titled "Artificial Intelligence Captures Structural Toxicity in Human In Vitro Cell Models on Thursday June 27 at 7pm in Poster Session II Even.
Come visit us at booth #2312, and see our poster P365 titled "A Novel Tool For Structural Toxicity Testing With In Vitro Models" on Thursday March 14 from 8:30am to 11:30am.
Dana Solutions announced today that it has entered into a Research Collaboration Agreement with the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research.
We were invited to present to researchers at the Gladstone Institutes, and talk about how PhenoLearn can be used for image-based phenotypic modeling, drug screening, quality control, and more.